chr6-158977803-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_031924.8(RSPH3):​c.992A>C​(p.His331Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00153 in 1,614,150 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H331R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0082 ( 22 hom., cov: 32)
Exomes 𝑓: 0.00083 ( 18 hom. )

Consequence

RSPH3
NM_031924.8 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.82

Publications

0 publications found
Variant links:
Genes affected
RSPH3 (HGNC:21054): (radial spoke head 3) The protein encoded by this gene acts as a protein kinase A anchoring protein. Mutations in this gene cause primary ciliary dyskinesia; a disorder characterized by defects of the axoneme in motile cilia and sperm flagella. The homolog of this gene was first identified in the blue-green algae Chlamydomonas as encoding a radial spoke protein that formed a structural component of motile cilia and flagella. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Dec 2016]
RSPH3 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 32
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Ambry Genetics
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003074646).
BP6
Variant 6-158977803-T-G is Benign according to our data. Variant chr6-158977803-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0082 (1249/152330) while in subpopulation AFR AF = 0.0284 (1180/41572). AF 95% confidence interval is 0.027. There are 22 homozygotes in GnomAd4. There are 629 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH3NM_031924.8 linkc.992A>C p.His331Pro missense_variant Exon 8 of 8 ENST00000367069.7 NP_114130.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH3ENST00000367069.7 linkc.992A>C p.His331Pro missense_variant Exon 8 of 8 1 NM_031924.8 ENSP00000356036.1
RSPH3ENST00000449822.6 linkc.704A>C p.His235Pro missense_variant Exon 6 of 6 2 ENSP00000393195.1

Frequencies

GnomAD3 genomes
AF:
0.00819
AC:
1247
AN:
152212
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0284
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00232
AC:
581
AN:
250852
AF XY:
0.00164
show subpopulations
Gnomad AFR exome
AF:
0.0318
Gnomad AMR exome
AF:
0.00133
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000883
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.000830
AC:
1213
AN:
1461820
Hom.:
18
Cov.:
32
AF XY:
0.000719
AC XY:
523
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.0296
AC:
992
AN:
33474
American (AMR)
AF:
0.00148
AC:
66
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000342
AC:
38
AN:
1111996
Other (OTH)
AF:
0.00172
AC:
104
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
66
132
197
263
329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00820
AC:
1249
AN:
152330
Hom.:
22
Cov.:
32
AF XY:
0.00844
AC XY:
629
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0284
AC:
1180
AN:
41572
American (AMR)
AF:
0.00340
AC:
52
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68034
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
59
118
177
236
295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00301
Hom.:
21
Bravo
AF:
0.00957
ESP6500AA
AF:
0.0340
AC:
150
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00288
AC:
350
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 32 Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 20, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Nov 11, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

RSPH3-related disorder Benign:1
Apr 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.0030
DANN
Benign
0.24
DEOGEN2
Benign
0.027
T;.;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.40
T;T;T
MetaRNN
Benign
0.0031
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
.;.;L
PhyloP100
-3.8
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.9
N;N;N
REVEL
Benign
0.018
Sift
Benign
0.16
T;T;T
Sift4G
Benign
0.22
T;T;T
Vest4
0.13
ClinPred
0.0038
T
GERP RS
-5.3
Varity_R
0.097
gMVP
0.39
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78116655; hg19: chr6-159398835; API